AI Article Synopsis

  • Pseudorabies virus (PRV) can create lifelong infections in nerve cells and blood lymphocytes, avoiding the immune system and potentially causing fetal death.
  • The virus evades immune responses by downregulating swine leukocyte antigen class I (SLA I) molecules, but the specific mechanisms behind this suppression are poorly understood.
  • Research shows that PRV proteins pUL44 and pUS6 significantly decrease SLA I expression, with pUS6 also affecting transport proteins that help present antigens, highlighting how PRV can hinder immune detection.

Article Abstract

Pseudorabies virus (PRV) can establish lifelong latent infection in peripheral nervous ganglion, and persistent infections in peripheral blood lymphocytes. Establishing an infection in the lymphocytes does not only enable the PRV to escape host immune surveillance but pass through the placental barrier, leading to fetal death and abortion. Due to the pathogenicity of the PRV, it poses a huge challenge in its prevention and control. The PRV escapes host immunity through downregulation of swine leukocyte antigen class I (SLA I) molecules on infected cells. However, data on the molecular mechanisms of the SLA I suppression remains scant. Here, in order to verify the effect of candidate proteins PRV pUL44 and pUS6 on PRV immune escape related molecules SLA I and peptide loading complex (PLC), we detected the expression of SLA I and PLC components after expressing PRV pUL44 and pUS6. The effects of pUS6 and pUL44 on SLA I and PLC were analyzed by qRT-PCR and Western blot at mRNA and protein level, respectively. Cells expressing pUS6 or pUL44 genes showed a significantly suppressed expression of surface and total SLA I molecules. In addition, unlike UL44, the US6 gene was shown to downregulate the transporter associated with antigen processing 1 (TAP1), TAP2 and Tapasin molecules. The results show that PRV pUS6 may participate in virus immune escape by directly regulating the SLA I, TAP dimer and Tapasin molecules, thus blocking the transportation of TAP-bound peptides to the ER to bind SLA I molecules. We provide a theoretical basis on the mechanism of TAP mediated immune escape by the PRV.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11463114PMC
http://dx.doi.org/10.1186/s12917-024-04294-3DOI Listing

Publication Analysis

Top Keywords

sla molecules
12
immune escape
12
prv
9
pseudorabies virus
8
peptide loading
8
loading complex
8
sla
8
prv pul44
8
pul44 pus6
8
sla plc
8

Similar Publications

Recent progress in the 3D printing of microneedle patches for biomedical applications.

Int J Pharm

January 2025

Key Laboratory of Cluster Science of Ministry of Education, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering of Ministry of Industry and Information Technology, School of Chemistry and Chemical Engineering, Beijing Institute of Technology, 100081 Beijing, China. Electronic address:

Article Synopsis
  • 3D-printed microneedles (MNs) are a game-changing technology for drug delivery and diagnostics, offering a less invasive alternative to traditional methods.
  • The review covers advancements in 3D printing techniques such as FDM, DLP, and SLA, allowing for customized MN designs that enhance drug delivery and biosensing.
  • Despite their promise, challenges like regulatory issues, biocompatibility of materials, and scaling up manufacturing need to be addressed for 3D-printed MNs to transform healthcare successfully.
View Article and Find Full Text PDF

TGEV nonstructural protein ORF3b upregulates the expression of SLA-DR at the transcriptional level in monocyte-derived porcine dendritic cells.

Microbes Infect

November 2024

International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, 450046, China; Ministry of Education Key Laboratory for Animal Pathogens and Biosafety, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, 450046, China. Electronic address:

Article Synopsis
  • Transmissible gastroenteritis virus (TGEV) is a harmful coronavirus that can lead to deadly intestinal diseases in young pigs, particularly those under two weeks old, with a lethal outcome rate of 100%.
  • The research utilized monocyte-derived porcine dendritic cells (DCs) to examine how TGEV interacts with these important immune cells, revealing that TGEV can replicate in these cells while UV-inactivated TGEV cannot.
  • Findings showed that TGEV infection significantly raised the expression of SLA-DR, a crucial molecule for immune response, and that the ORF3b protein of TGEV enhances this expression at a transcriptional level, shedding light on the virus's pathogenic mechanisms.
View Article and Find Full Text PDF

Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trial.

Lancet Neurol

November 2024

Department of Neurology, Klinikum rechts der Isar, Technical University Munich, School of Medicine and Health, Munich, Germany; German Center for Neurodegenerative Diseases, Site Munich, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. Electronic address:

Background: Fasudil is a small molecule inhibitor of Rho-associated kinase (ROCK) and is approved for the treatment of subarachnoid haemorrhage. In preclinical studies, fasudil has been shown to attenuate neurodegeneration, modulate neuroinflammation, and foster axonal regeneration. We aimed to investigate the safety, tolerability, and efficacy of fasudil in patients with amyotrophic lateral sclerosis.

View Article and Find Full Text PDF
Article Synopsis
  • Pseudorabies virus (PRV) can create lifelong infections in nerve cells and blood lymphocytes, avoiding the immune system and potentially causing fetal death.
  • The virus evades immune responses by downregulating swine leukocyte antigen class I (SLA I) molecules, but the specific mechanisms behind this suppression are poorly understood.
  • Research shows that PRV proteins pUL44 and pUS6 significantly decrease SLA I expression, with pUS6 also affecting transport proteins that help present antigens, highlighting how PRV can hinder immune detection.
View Article and Find Full Text PDF
Article Synopsis
  • Microphysiological systems (MPSs) offer a promising alternative to animal models in drug development by reconstituting tissue interfaces and organ functions, although traditional materials like PDMS can interfere with drug testing accuracy.
  • The GlioFlow3D platform combines 3D bioprinting and stereolithography to create hydrogel-based microchannels that better mimic human vasculature, integrating human cells and glioblastoma lines while using cost-effective materials and protocols to reduce cytotoxicity.
  • This platform allows for improved drug testing accuracy, demonstrated through lower absorption of small molecules like Temozolomide, and reveals complex GBM drug resistance mechanisms influenced by the tissue microenvironment, enhancing potential for personalized therapy.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!